randomized [resa]
DOUBLE BLIND [resa]
Parallel [qlco]
Group [idcn]
Trial [resa]
Antihypertensive [phsu]
Efficacy [qlco]
TOLERABILITY [resa]
Combination [qlco]
Daily [tmco]
Losartan [orch, phsu]
Hydrochlorothiazide 12.5 MG [clnd]
Compared [acty]
Losartan [orch, phsu]
mg% [qnco]
treatment [ftcn]
Mild [qlco]
Severe [qlco]
Essential [qlco]
Hypertension [dsyn]
Patients [podg]
Hypertension [dsyn]
Antihypertensive agent [phsu]
Blood Pressure [orgf]
Physicians [prog]
Often [tmco]
Fixed [fndg]
Combination [qlco]
Antihypertensive [phsu]
Medications [phsu]
Objective [inpr]
Study [mnob]
Evaluated [ftcn]
ADD [mobd]
Low dose [qnco]
Hydrochlorothiazide 12.5 MG [clnd]
High dose [qnco]
Losartan [orch, phsu]
mg% [qnco]
Patients [podg]
Hypertension [dsyn]
Blood Pressure [orgf]
Controlled [ftcn]
Losartan [orch, phsu]
mg% [qnco]
Methods [inpr]
randomized [resa]
DOUBLE BLIND [resa]
Parallel [qlco]
Group [idcn]
Filter [mnob]
Study [mnob]
Patients [podg]
Aged [orga]
Trough [qnco]
Sitting diastolic blood pressure [fndg]
mmHg [qnco]
Patients [podg]
treated [topp]
Losartan [orch, phsu]
mg% [qnco]
QD [tmco]
4 Weeks [tmco]
Patients [podg]
Adequate [qlco]
Blood Pressure [orgf]
Assigned [ftcn]
Receive [qlco]
Losartan [orch, phsu]
mg/mg [qnco]
Hydrochlorothiazide [orch, phsu]
Losartan [orch, phsu]
mg% [qnco]
QD [tmco]
weeks [tmco]
Primary [qlco]
Efficacy [qlco]
Measure [qnco]
Trough [qnco]
Sitting [fndg]
diastolic bp [clna]
baseline [bodm]
Group [idcn]
Defined [cnce]
Patients [podg]
Trough [qnco]
Sitting [fndg]
diastolic bp [clna]
>90 [qnco]
Hg [elii, hops]
Patients [podg]
A-10 [orch, phsu]
mmHg [qnco]
Decrease [qlco]
Trough [qnco]
Sitting [fndg]
diastolic bp [clna]
demographic [ocdi]
Characteristics [qlco]
treatment [ftcn]
Group [idcn]
Patients [podg]
randomized [resa]
DOUBLE BLIND [resa]
treatment [ftcn]
White [popg]
Age [orga]
Duration [tmco]
Hypertension [dsyn]
baseline [bodm]
Proportion [qnco]
Patients [podg]
treated [topp]
Antihypertensive therapy [topp]
Patients [podg]
Losartan [orch, phsu]
mg% [qnco]
Filter [mnob]
Patients [podg]
Blood Pressure [orgf]
Controlled [ftcn]
randomized [resa]
Receive [qlco]
Losartan [orch, phsu]
mg% [qnco]
N NOS [aapp, imft]
Losartan [orch, phsu]
mg/mg [qnco]
Hydrochlorothiazide [orch, phsu]
N NOS [aapp, imft]
Randomization [resa]
Trough [qnco]
Sitting [fndg]
diastolic bp [clna]
Losartan/Hydrochlorothiazide [orch, phsu]
mg% [qnco]
Group [idcn]
Losartan [orch, phsu]
mg% [qnco]
Group [idcn]
P NOS [aapp, imft]
Between [spco]
Group [idcn]
mmHg [qnco]
P NOS [aapp, imft]
Proportion [qnco]
Losartan/Hydrochlorothiazide [orch, phsu]
mg% [qnco]
Group [idcn]
Losartan [orch, phsu]
mg% [qnco]
Group [idcn]
P NOS [aapp, imft]
adverse events [fndg]
Patients [podg]
DOUBLE BLIND [resa]
Group [idcn]
adverse events [fndg]
Losartan [orch, phsu]
mg% [qnco]
Group [idcn]
Losartan/Hydrochlorothiazide [orch, phsu]
mg% [qnco]
Group [idcn]
included [ftcn]
Respiratory tract infection [dsyn]
3 4 [fndg]
Dizziness [sosy]
Headache [sosy]
3 4 [fndg]
Conclusions [idcn]
weeks [tmco]
therapy [ftcn]
Losartan [orch, phsu]
mg/mg [qnco]
Hydrochlorothiazide [orch, phsu]
Antihypertensive [phsu]
Efficacy [qlco]
Losartan [orch, phsu]
mg% [qnco]
Measured [qlco]
Trough [qnco]
Percentage [qnco]
Losartan/Hydrochlorothiazide [orch, phsu]
mg% [qnco]
Group [idcn]
Losartan [orch, phsu]
mg% [qnco]
Group [idcn]
CLIN [inpr]
Copyright [inpr]
